Prevalence, Duration, Severity, and Distress of Chemotherapy-Related Gastrointestinal Symptoms in Patients With a Hematologic Malignancy.
Purpose/Objectives: To describe prevalence, duration, severity, and distress of chemotherapy-related gastrointestinal (GI) symptoms, and evaluate inclusion of clinically relevant GI symptom items on cancer symptom questionnaires. Design: Longitudinal descriptive design. Setting: Inpatient and outpat...
| Publicado en: | Oncology Nursing Forum Vol. 43; no. 5; pp. 561 - 572 |
|---|---|
| Autor principal: | |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oncology Nursing Society
Sep2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=117549901&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 117549901 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0190535X 4F0 jtl: Oncology Nursing Forum issn: 0190535X maglogo: N pubinfo: dt: Sep2016 vid: 43 iid: 5 pid: 12496 pub: Oncology Nursing Society place: Pittsburgh, Pennsylvania artinfo: ui: 117549901 117549901 117549901 10.1188/16.ONF.43-05AP 117549901 ppf: 561 ppct: 11 formats: fmt: @attributes: type: P tig: atl: Prevalence, Duration, Severity, and Distress of Chemotherapy-Related Gastrointestinal Symptoms in Patients With a Hematologic Malignancy. aug: au: Cherwin, Catherine affil: Professor, School of Nursing, University of Wisconsin, Madison sug: subj: Hematologic Neoplasms Drug Therapy Chemotherapy, Adjuvant Adverse Effects Stress, Psychological Gastrointestinal Diseases Epidemiology Gastrointestinal Diseases Chemically Induced Human Prospective Studies Descriptive Research Prevalence Severity of Illness Gastrointestinal Diseases Symptoms Descriptive Statistics Questionnaires Comparative Studies Convenience Sample Self Report Comorbidity Scales Middle Age Male Female Funding Source Middle Aged: 45-64 years Male Female ab: Purpose/Objectives: To describe prevalence, duration, severity, and distress of chemotherapy-related gastrointestinal (GI) symptoms, and evaluate inclusion of clinically relevant GI symptom items on cancer symptom questionnaires. Design: Longitudinal descriptive design. Setting: Inpatient and outpatient hematology settings. Sample: 105 adults with a hematologic malignancy receiving their third or subsequent cycle of chemotherapy. Methods: Participants completed weekly assessments of 19 GI symptoms during a three-week period of chemotherapy. Descriptive statistics were calculated to summarize GI symptom prevalence, duration, severity, and distress ratings at each week. Findings were compared to item content of 12 cancer multisymptom questionnaires identified in the literature. Main Research Variables: GI symptom prevalence, duration, severity, and distress. Findings: Participants reported an average of three to five GI symptoms at each time point that were typically experienced as mild to moderate in duration, severity, and distress. Only 3 of 11 clinically relevant GI symptoms were included on more than half of the cancer symptom questionnaires. Conclusions: Patients receiving chemotherapy experience a moderate GI symptom burden across a wide range of potential GI symptoms. Implications for Nursing: Future research should include measures of clinically relevant GI symptoms that may be emerging with new cancer therapies and toxicity prevention protocols. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|